This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Wearable devices that are being trialled by Parkinson’s UK to improve symptom management for sufferers have been granted an EU patent, signalling a green light for the devices to enter the European market in the near future.
The Global Kinetics Corporation’s (GCK) KinetiGraph device, worn on the wrist, records patients’ movements and medication to assess dosage levels and their effectiveness. Charity Parkinson’s UK announced in Autumn 2014 that it would trial the wearables on hundreds of patients over the next 12 months.
Source: Techworld